Skip to main content
Skip to content
Case File
efta-02623019DOJ Data Set 11Other

EFTA02623019

Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02623019
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Sent: To: jeffrey E. <jeevacation@gmail.com> Friday, September 21, 2018 4:57 AM Teva's NOW The drug, which is the first and onl= anti-CGRP treatment, is a preventative treatment of migraines in adults. The WAC — Whol=sale Acquisition Cost — for a monthly dose is $585 and $1,725 for a quarterly dose. P conversation-id 327915 date-last-viewed 0 date-received 1537505849 flags 8590195713 remote-id 855159 EFTA_R1_01831580 EFTA02623019

Technical Artifacts (3)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Emailjeevacation@gmail.com
Phone2623019
Phone7505849

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.